PUBLICACIÓN

Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Vuorinen A. et al.

2021 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Drug Discovery (Q1), Medicine (miscellaneous) (Q1), Organic Chemistry (Q1), Pharmacology (Q1)

JCR: 7.088

SJR: 1.054


CITAS

11

DOI

10.1016/j.ejmech.2021.113431

EID

2-s2.0-85108022709

ISSN

0223-5234

EISSN

1768-3254

BIBTEX

@article{Vuorinen_2021, doi = {10.1016/j.ejmech.2021.113431}, url = {https://doi.org/10.1016%2Fj.ejmech.2021.113431}, year = 2021, month = {aug}, publisher = {Elsevier {BV}}, volume = {220}, pages = {113431}, author = {Aini Vuorinen and Isabel V.L. Wilkinson and Maria Chatzopoulou and Ben Edwards and Sarah E. Squire and Rebecca J. Fairclough and Noelia Araujo Bazan and Josh A. Milner and Daniel Conole and James R. Donald and Nandini Shah and Nicky J. Willis and R. Fernando Mart{\'{\i}}nez and Francis X. Wilson and Graham M. Wynne and Stephen G. Davies and Kay E. Davies and Angela J. Russell}, title = {Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy}, journal = {European Journal of Medicinal Chemistry}}


AUTORES DE LA UEX